Articles from Kaskela Law
Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”) on behalf of the company’s current shareholders.
By Kaskela Law · Via Business Wire · August 19, 2026
Kaskela Law announces that it is investigating Finance of America Companies Inc. (NYSE: FOA) (“Finance of America”) on behalf of the company’s current stockholders.
By Kaskela Law · Via Business Wire · August 19, 2026
Kaskela Law announces that it is investigating Houlihan Lokey, Inc. (NYSE: HLI) (“Houlihan Lokey”) on behalf of the company’s shareholders.
By Kaskela Law · Via Business Wire · August 19, 2026
Kaskela Law is investigating the fairness of the proposed Utz Brands, Inc. (NYSE: UTZ) (“Utz”) shareholder buyout to determine whether Utz shareholders may be able to obtain a higher price for their shares.
By Kaskela Law · Via Business Wire · July 27, 2026
Investor protection firm Kaskela Law is investigating Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) on behalf of the company’s shareholders to determine whether the recently announced proposed buyout of SEM shareholders is fair and provides investors with sufficient monetary consideration for their shares.
By Kaskela Law · Via Business Wire · May 7, 2026
